|
Addgene inc
pcmv ancbe4max p2a gfp plasmid ![]() Pcmv Ancbe4max P2a Gfp Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ancbe4max/pCMV_AncBE4max_P2A_GFP+(Plasmid+%23112100)/bio_rxiv__64898__2026__10__14__759016-346-28-30 Average 94 stars, based on 1 article reviews
pcmv ancbe4max p2a gfp plasmid - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Addgene inc
pef ancbe4max ![]() Pef Ancbe4max, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ancbe4max/pEF-AncBE4max+(Plasmid+%23138270)/pm42880244-307-8-9 Average 93 stars, based on 1 article reviews
pef ancbe4max - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
recombinant dna ancbe4max addgene ![]() Recombinant Dna Ancbe4max Addgene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ancbe4max/pCMV_AncBE4max+(Plasmid+%23112094)/pm42800828-181-58-61 Average 93 stars, based on 1 article reviews
recombinant dna ancbe4max addgene - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
pcmv ancbe4max ![]() Pcmv Ancbe4max, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ancbe4max/pCMV_AncBE4max+(Plasmid+%23112094)/pmc12905999-79-0-2 Average 93 stars, based on 1 article reviews
pcmv ancbe4max - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
be4max ![]() Be4max, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ancbe4max/pCMV_AncBE4max+(Plasmid+%23112094)/bio_rxiv__64898__2026__01__21__700828-73-12-13 Average 93 stars, based on 1 article reviews
be4max - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
dr timothy phoenix n a pcmv ancbe4max addgene ![]() Dr Timothy Phoenix N A Pcmv Ancbe4max Addgene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ancbe4max/pCMV_AncBE4max+(Plasmid+%23112094)/pm41576930-276-33-38 Average 93 stars, based on 1 article reviews
dr timothy phoenix n a pcmv ancbe4max addgene - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
ancbe4max ![]() Ancbe4max, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/ancbe4max/pCMV_AncBE4max+(Plasmid+%23112094)/us12529042-193-17-18 Average 93 stars, based on 1 article reviews
ancbe4max - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
Journal: bioRxiv
Article Title: Self-extending DNA recording with stochastic and programmed writing
doi: 10.64898/2026.10.14.759016
Figure Lengend Snippet: Figure 2 legend a, CCA-register extension and specified-product overview for Infinite Printer–Programmed Writing (IP-PW; construct V21m). Only a terminal segment is illustrated; the experimental starting recorder contains four CCA units. The BE-free experiment used transient PE expression from the original Addgene 174828 plasmid in CCA-stpegRNA-bearing HEK293T cells. b, The stpegRNA supplies terminal extension, whereas aux pegRNAs provide payload templates. CCA replaces AC at the design stage; its reverse complement, TGG, supplies the opposite-strand NGG PAM context for aux targeting, distinct from the terminal GGG PAM used by stpegRNA. The corresponding explanation is placed beside each structure. M2 points to the aux-domain structure and its recognition view in c. c, Target recognition at left and opposite-strand templating and repair at right, retaining the 9-nt PBS, 9-nt RTT and GTT example. The illustrated nick and intermediates are schematic, not experimentally mapped coordinates. Recorder-forward DNA is displayed left to right, 5 ′ to 3 ′ ; the opposite strand retains its antiparallel orientation. Blue identifies spacer/target DNA, teal scaffold and retained terminal context, ochre RTT, purple PBS, vermilion PAM and navy the GTT example payload, which belongs to input pool 1 in d,e. d, Three aux-payload pools introduced at D0, D7 and D14, each co-transfected with the original PE plasmid, followed by D21 harvest. Navy, vermilion and teal identify the three pools. e, The four complete endpoints retain +2 CCA without payload and three, four and five payload-bearing positions, supported by 2,590, 346, 37 and 8 exact read pairs, respectively. Light-grey boxes denote CCA; teal outlines denote terminal GCA. Payload colours and coloured counts retain D0/D7/D14 pool membership. All endpoints were collected at D21; input-pool labels identify supplied sequences and transfection days, not independently recovered incorporation times. Complete-endpoint distributions remain in . Counts are non-UMI, PCR-weighted original read-pair occurrences from one HEK293T sample (biological n = 1).
Article Snippet: The bulk targeted-DNA experiments supporting and used the original pCMV-PEmax-P2A-hMLH1dn plasmid (Addgene 174828) for transient PE expression where PE was required and, where BE was required, the original
Techniques: Construct, Expressing, Plasmid Preparation, Transfection
Journal: bioRxiv
Article Title: Self-extending DNA recording with stochastic and programmed writing
doi: 10.64898/2026.10.14.759016
Figure Lengend Snippet: a, Four retained-5 ′ -sequence-compatible paths assembled from observed exact endpoints. Dashed connections indicate compatibility and explicit breaks mark missing intermediate endpoints. Terminal labels report length, evidence tier and graph membership. b, Left, sequence-resolved path containing 26 exact endpoints from 5 ′ -(AC)8-GCA-3 ′ at 19 bp to 5 ′ -(AC)147-GCA-3 ′ at 297 bp. Blue units are retained AC dinucleotides, ochre units are newly resolved sequence, hatching marks sequence across missing intermediate endpoints and teal marks terminal GCA. Right, independent 19-, 21-, 23-, 25- and 29-bp endpoints retaining the same 5 ′ AT × 3-compatible mark as AC units are added; all five occur in transcriptome-derived cDNA, non-UMI targeted DNA and UMI-tagged targeted DNA. c, Occurrence-weighted read fractions carrying at least one C-to-T-compatible mark within the first eight repeat units, calculated separately within the reference-length and expanded designed-register classes, in eight non-UMI targeted DNA libraries. These libraries came from eight independently cultured HEK293T dishes harvested 7 days after transient editor transfection (four BE plus stpegRNA and four PE plus BE plus stpegRNA). Stable stpegRNA-expressing HEK293T cells were distributed into eight dishes before editor introduction. In the PE-containing group, the original PE and BE plasmids were co-transfected into each dish. Lines connect measurements from the same library and large symbols show medians. This comparison is descriptive and is not a formal BE-PE interaction test. d, Left, equal-state Shannon information after progressive 5 ′ prefix projection of the fixed 69-state cross-library-type expanded catalogue. Right, a selection-conditioned permutation diagnostic for the same catalogue (observed, 69; null mean, 45.91; 95% interval, 37-55; empirical upper-tail P=1/10,001). Because catalogue admission required detection in all three layers, the right-hand comparison is an audit rather than an independent recurrence test. Endpoint ordering denotes retained-sequence compatibility rather than tracked transitions, time, cycles or ancestry.
Article Snippet: The bulk targeted-DNA experiments supporting and used the original pCMV-PEmax-P2A-hMLH1dn plasmid (Addgene 174828) for transient PE expression where PE was required and, where BE was required, the original
Techniques: Sequencing, Derivative Assay, Cell Culture, Transfection, Expressing, Comparison, Selection, Diagnostic Assay
Journal: bioRxiv
Article Title: AlphaGenome-enabled analysis of non-coding regulatory variants underlying RHD expression
doi: 10.64898/2026.01.21.700828
Figure Lengend Snippet: Sequence view of the genomic region surrounding the RHD transcription start site (chr1:25272354–25272950, hg38), highlighting two AG-prioritized non-coding variants selected for experimental validation: chr1:25272422 (c.1–83 C>T, highlighted in yellow) and chr1:25272434 (G>A, highlighted in orange). The displayed nucleotide sequence provides the exact genomic context used for sgRNA design and evaluation of the BE4max editing window, including the relative positions of target bases and potential bystander nucleotides. Both variants reside within a promoter-proximal regulatory region predicted by AG to exert suppressive effects on RHD expression.
Article Snippet: To introduce the target SNPs (chr1:25272422 C>T and chr1:25272434 G>A), we employed
Techniques: Sequencing, Biomarker Discovery, Expressing